Shares of TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) were up 0.5% on Wednesday . The stock traded as high as $1.11 and last traded at $1.11. Approximately 7,434 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 24,265 shares. The stock had previously closed at $1.10.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen began coverage on shares of TherapeuticsMD in a research note on Wednesday, May 21st. They set a “hold” rating for the company.
Get Our Latest Stock Analysis on TherapeuticsMD
TherapeuticsMD Price Performance
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($0.06) earnings per share for the quarter. The company had revenue of $0.39 million during the quarter. TherapeuticsMD had a negative return on equity of 7.86% and a negative net margin of 114.07%.
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Stories
- Five stocks we like better than TherapeuticsMD
- What is the S&P/TSX Index?
- RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum?
- What is the Dogs of the Dow Strategy? Overview and Examples
- How DigitalOcean’s Focus Is Fueling Explosive Growth
- How to Start Investing in Real Estate
- Can Celsius Stock Keep Its Momentum Going Any Longer?
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
